The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.50
Bid: 14.00
Ask: 15.00
Change: 0.50 (3.57%)
Spread: 1.00 (7.143%)
Open: 14.00
High: 15.00
Low: 14.00
Prev. Close: 14.00
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Franchise Brands trading in line; Tribe secures loan

Wed, 25th Oct 2023 17:28

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

First Tin PLC - London-based tin development company, fotheycused on advanced, low-capital expenditure projects in Germany and Australia - Updates on the definitive feasibility study at its Taronga tin project in Australia. The project is owned by First Tin's 100% owned Australian subsidiary, Taronga Mines Pty Ltd. Explains the resource is significantly larger than estimated due to a combination of, a lower cut-off grade and newly identified mineralisation to the south-west. As a result, a higher throughput has been decided on for the DFS, resulting in economies of scale. Expects completion of the DFS in the first quarter of 2024. Chief Executive Thomas Buenger says: "We are pleased with the DFS outcomes at our flagship Taronga tin deposit, which have validated our assumptions held prior to the study. The simple mineralogy and subsequent mineral processing characteristics, combined with the low strip ratio and open pit mineability of the deposit, make it one of the most straightforward hard rock tin deposits in the world."

----------

Molecular Energies PLC - oil, gas and alternative energy company with an exploration asset in Paraguay - Says final on-site commissioning of the drilling rig in Paraguay is taking place. Understands from the drilling company that the repaired blow out preventer has passed its operational tests in Brazil, from where it is due to be shipped, and is currently expected to be on site at or around the end of the second week of November. Explains the BOP is a critical safety component of the drilling rig and Molecular will not authorise any drilling activities unless it receives certification. Points out the well, if successful, will potentially unlock a complex of prospects, estimated to contain in aggregate over 260 million of barrels of oil. The potential of the prize makes this exploration well compelling, company says. Further, notes the cash flow from the recent sale of the Argentine hydrocarbon assets will commence during 2024, providing an uplift to the company's financial position. Thereafter, and irrespective of the outcome of the Paraguay exploration programme, intends to focus resources on originating and developing alternative energy projects of scale with attractive long-term returns. Also plans to pursue interests in sustainable aviation fuels.

----------

Power Metal Resources PLC - metals exploration company focused on North America, Africa, and Australia - Provides business update following end of financial year to September 30. Chief Executive Sean Wade says he expects "various news updates in the near term, informing shareholders of the outcomes of current exploration programmes, the launch of new exploration activities and the results of our corporate activities seeking value crystallisation and streamlining of the company." Says short term objectives are to complete transactions with third parties looking to acquire business interests, and enter into joint ventures; to focus on major metal discoveries from its retained in-house portfolio; to expand the ownership of Power Metal shares into new investor groups; identify new territories for future business opportunities, including notably Saudi Arabia and Oman; and focus on value growth in the Power Metal portfolio through exploration and value crystallisation, so as to materially increase the company's market valuation.

----------

Tribe Technology PLC - Belfast-based developer and manufacturer of autonomous mining equipment - Enters into a GBP3.0 million secured term loan facility agreement with BPC UK Lending DAC. Explains funds will refinance the legacy debt arrangements and further progress the previously outlined execution strategy. Following drawdown of the facility, the company will have repaid its entire GBP0.52 million existing debt facility with Growth Finance Fund LP inclusive of accrued interest and fees. The facility is for a five-year term and bears interest at 13% per year.

----------

Franchise Brands PLC - Manchester-based owner of ChipsAway, Willow Pumps and Metro Rod brands - Provides trading update for the three months to September 30. Reports the business to business units, are all trading at record levels despite some softening in demand over the summer period. Consequently, the third quarter was a little softer than in the first half, but there was a modest increase in activity at the start of the fourth quarter. Says Pirtek is integrating well and has met expectations at the time of its acquisition. Plans to accelerate the integration process. States the business to consumer division continues to operate in a challenging environment, although profitability is being maintained in line with expectations. Group debt has reduced to GBP76.0 million as at September 30 from GBP79.1 million at June 30, and the company is trading comfortably within key banking covenants. Expects adjusted earnings before interest, tax and amortisation for the year ending December 2023 to be in line with current consensus market expectations.

----------

Sound Energy PLC - London-based, Morocco-focused upstream gas company - Confirms the extension of both the Office National de l'Electricite et de l'Eau Potable gas sales agreement and the Attijariwafa bank funding offer until December 31. Graham Lyon executive chair says: "Various elements within the GSA are being amended to meet the debt funders criteria and to meet international standards. As such, Sound Energy, ONHYM, ONEE and Attijariwafa bank are engaged under the auspices of the Ministry of Energy to conclude a revised GSA by year end."

----------

Angle PLC - Surrey, England-based medical diagnostics company - Publishes study using the Parsortix system that sheds new light on the phenotypic characteristics of circulating tumour cells in head and neck squamous cell carcinoma. The study demonstrates the feasibility of using mass cytometry for the comprehensive characterisation of CTCs captured by the Parsortix system in HNSCC patients. This enables simultaneous analysis of multiple proteins on and within individual CTCs, providing an understanding of their phenotypic status and diversity. HNSCC is an aggressive, genetically complex, and difficult to treat group of cancers with limited options for early detection and monitoring. Chief Scientific Officer, Karen Miller, says: "The Parsortix system allows for the unbiased isolation and harvest of CTCs and as such, can enable the evaluation of phenotypically diverse CTCs in a patient's blood. This could lead to future improvements in clinical decision making."

----------

Angus Energy PLC - UK-focused oil and gas development company - Ahead of general meeting, clarifies that the agreement with Kemexon, originally announced March 28, requires that any conversion of the loan into equity was conditional on a conversion being mutually agreed by Kemexon and the company. Explains that due to the company's financial position, the company was only able to agree conversion of the loan at a price per share of 0.66 pence. Recognises that this is below the initially intended conversion price of 1p. But, due to the drop in share price, feels it was a good result to have discharged a loan at market price and therefore at no discount to the prevailing share price.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 Apr 2024 17:06

CORRECT: No record close for FTSE 100; mixed trade in US

(Correcting day of the week in the opening sentence.)

Read more
24 Apr 2024 17:00

LONDON MARKET CLOSE: No record close for FTSE 100; mixed trade in US

(Alliance News) - Stock prices in London closed lower on Thursday, with the FTSE 100's recent rally taking a pause for breath, but not after hitting another record high.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
22 Apr 2024 16:52

IN BRIEF: Angle granted patents in US and Europe for Cellkeep slide

Angle PLC - Surrey-based medical diagnostics provider - Says it has been granted a European and US patent for its CellKeep slide. "We are delighted to have secured intellectual property rights for our proprietary CellKeep slide in two major jurisdictions....This is a significant technology advancement for the [circulating tumor cell] liquid biopsy field and another step towards enabling biomarker-guided precision medicine for people with cancer," says Chief Executive Officer Andrew Newland. The CellKeep slide was developed by Angle to reduce cell loss during the transfer of CTCs to the microscope slide and to protect the morphology of the harvested cells.

Read more
22 Apr 2024 06:59

Angle granted European patent for CellKeep, US patent imminent

(Sharecast News) - Liquid biopsy specialist Angle announced on Monday that it has received a European patent for its 'CellKeep' slide, as it anticipated the imminent grant of an equivalent US patent application.

Read more
22 Jan 2024 18:03

IN BRIEF: Angle highlights supportive data for DNA analysis tool

Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.

Read more
4 Jan 2024 16:54

LONDON MARKET CLOSE: Stocks up ahead of US nonfarm payrolls

(Alliance News) - Stock prices in London closed higher on Thursday, as investors eye the latest US non-farms data.

Read more
4 Jan 2024 12:19

Angle shares soar following "breakthrough" cancer diagnostics results

(Alliance News) - Angle PLC on Thursday said that "breakthrough results" from its latest blood sample cancer trials would allow it to expand its product sales and pharma services.

Read more
4 Jan 2024 12:09

LONDON MARKET MIDDAY: Retailers Next and JD Sports bookend FTSE 100

(Alliance News) - Stock prices in London were slightly higher at midday on Thursday, with the FTSE 100 looking set to snap the two-day losing streak it suffered at the start of the year.

Read more
4 Jan 2024 10:43

AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
4 Jan 2024 08:58

LONDON MARKET OPEN: Next leads buoyant FTSE 100 amid services PMIs

(Alliance News) - Stock prices in London opened up on Thursday, amid a slew of services PMI data, including for the UK, while reacting to the latest data from China.

Read more
4 Jan 2024 07:58

Angle receives 'breakthrough results' from DNA molecular analysis

(Sharecast News) - Liquid biopsy company Angle received "breakthrough results" from DNA molecular analysis of cancer patient blood samples on Thursday, sending its shares skywards as a result.

Read more
2 Jan 2024 09:04

Angle locks in $250,000 contract with Eisai

(Sharecast News) - Liquid biopsy company Angle has locked in a $250,000 contract with global pharmaceutical company Eisai to deliver circulating tumour cell analysis in a pilot study.

Read more
2 Jan 2024 08:51

IN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trial

Angle PLC - Surrey, England-based medical diagnostics - Signs contract with Eisai Inc, part of Tokyo-based pharmaceutical firm Eisai Co Ltd. Under the agreement, the two will engage in a pilot study worth USD250,000 to Angle. Angle will provide circulating-tumour-cells analysis using its Portrait HER2 assay to assess the response of breast cancer patients to Eisai's BB-1701 antibody-drug conjugate. BB-1701 targets HER2, a protein that speeds up the growth of breast cancer cells. Success in the phase two pilot study will offer the possibility for multiple follow-up studies.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.